GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fukuda Denshi Co Ltd (TSE:6960) » Definitions » Net Current Asset Value

Fukuda Denshi Co (TSE:6960) Net Current Asset Value : 円0.00 (As of Jun. 2024)


View and export this data going back to 1982. Start your Free Trial

What is Fukuda Denshi Co Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Fukuda Denshi Co's net current asset value per share for the quarter that ended in Jun. 2024 was 円0.00.

The historical rank and industry rank for Fukuda Denshi Co's Net Current Asset Value or its related term are showing as below:

During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Fukuda Denshi Co was 2.79. The lowest was 1.40. And the median was 1.97.

TSE:6960's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.345
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Fukuda Denshi Co Net Current Asset Value Historical Data

The historical data trend for Fukuda Denshi Co's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fukuda Denshi Co Net Current Asset Value Chart

Fukuda Denshi Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,881.74 2,145.57 2,449.81 2,738.84 2,743.33

Fukuda Denshi Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,909.69 2,852.30 2,743.33 - -

Competitive Comparison of Fukuda Denshi Co's Net Current Asset Value

For the Medical Devices subindustry, Fukuda Denshi Co's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fukuda Denshi Co's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Fukuda Denshi Co's Price-to-Net-Current-Asset-Value falls into.



Fukuda Denshi Co Net Current Asset Value Calculation

Fukuda Denshi Co's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Mar. 2024 is calculated as

Net Current Asset Value Per Share(A: Mar. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(119136-40059-0-0)/28.8252
=2,743.33

Fukuda Denshi Co's Net Current Asset Value (NCAV) per share for the quarter that ended in Jun. 2024 is calculated as

Net Current Asset Value Per Share(Q: Jun. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0-N/A-0-0)/28.8252
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fukuda Denshi Co  (TSE:6960) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Fukuda Denshi Co Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Fukuda Denshi Co's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Fukuda Denshi Co Business Description

Traded in Other Exchanges
N/A
Address
39-4, Hongo 3-chome, Bunkyo-ku, Tokyo, JPN, 113-8483
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.

Fukuda Denshi Co Headlines

No Headlines